|
A549
|
IC50 |
1.3 2
Compound: Melatonin
|
Growth inhibition of human A549 cells
Growth inhibition of human A549 cells
|
[PMID: 28814374]
|
|
A549
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
EC50 |
0.026 1
Compound: melatonin
|
Agonist activity at human MT1 receptor expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP release after 30 mins by multilabel plate reader
Agonist activity at human MT1 receptor expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP release after 30 mins by multilabel plate reader
|
[PMID: 21568291]
|
|
A549
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
AGS
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
Melanophore
|
EC50 |
0.063 1
Compound: melatonin
|
Agonist activity in Xenopus laevis melanophore assessed as potency for pigment aggregation
Agonist activity in Xenopus laevis melanophore assessed as potency for pigment aggregation
|
[PMID: 16759094]
|
|
AGS
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
EC50 |
0.069 1
Compound: melatonin
|
Agonist activity at human melatonin receptor-2 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
Agonist activity at human melatonin receptor-2 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
|
[PMID: 26023814]
|
|
BT-549
|
IC50 |
|
Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay
Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
C6
|
IC50 |
> 40 3
Compound: Melatonin
|
Antiproliferative activity against rat C6 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against rat C6 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
CHO
|
EC50 |
0.098 1
Compound: melatonin
|
Agonist activity at human melatonin receptor-1 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
Agonist activity at human melatonin receptor-1 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
|
[PMID: 26023814]
|
|
BT-549
|
IC50 |
|
Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay
Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
CHO
|
EC50 |
0.026 1
Compound: melatonin
|
Agonist activity at human MT1 receptor expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP release after 30 mins by multilabel plate reader
Agonist activity at human MT1 receptor expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP release after 30 mins by multilabel plate reader
|
[PMID: 21568291]
|
|
HEK293
|
IC50 |
0.2 1
Compound: Melatonin, MLT
|
Displacement of 2-[125I]iodomelatonin from human MT1 receptor expressed in HEK293 cells
Displacement of 2-[125I]iodomelatonin from human MT1 receptor expressed in HEK293 cells
|
[PMID: 18372181]
|
|
CHO
|
EC50 |
0.069 1
Compound: melatonin
|
Agonist activity at human melatonin receptor-2 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
Agonist activity at human melatonin receptor-2 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
|
[PMID: 26023814]
|
|
A549
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human A549 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
C6
|
IC50 |
> 40 3
Compound: Melatonin
|
Antiproliferative activity against rat C6 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against rat C6 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
CHO
|
EC50 |
0.098 1
Compound: melatonin
|
Agonist activity at human melatonin receptor-1 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
Agonist activity at human melatonin receptor-1 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
|
[PMID: 26023814]
|
|
CHO-K1
|
IC50 |
0.21 1
Compound: melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant melatonin receptor 1 expressed in CHOK1 cells after 3 hrs
Displacement of [125I]2-iodomelatonin from human recombinant melatonin receptor 1 expressed in CHOK1 cells after 3 hrs
|
[PMID: 23403082]
|
|
CHO
|
EC50 |
0.026 1
Compound: melatonin
|
Agonist activity at human MT1 receptor expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP release after 30 mins by multilabel plate reader
Agonist activity at human MT1 receptor expressed in CHO cells assessed as decrease in forskolin-stimulated cAMP release after 30 mins by multilabel plate reader
|
[PMID: 21568291]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human melatonin MT2 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
Intrinsic activity at human melatonin MT2 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
|
[PMID: 24417958]
|
|
Melanophore
|
EC50 |
0.23 1
Compound: Melatonin
|
Effective concentration required to produce 50% of the maximal pigment aggregation in Xenopus laevis dermal melanophore cell line
Effective concentration required to produce 50% of the maximal pigment aggregation in Xenopus laevis dermal melanophore cell line
|
[PMID: 9484496]
|
|
CHO
|
EC50 |
0.069 1
Compound: melatonin
|
Agonist activity at human melatonin receptor-2 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
Agonist activity at human melatonin receptor-2 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
|
[PMID: 26023814]
|
|
CHO
|
EC50 |
0.098 1
Compound: melatonin
|
Agonist activity at human melatonin receptor-1 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
Agonist activity at human melatonin receptor-1 transfected in CHO cell membranes after 1 hr by GTPgammaS binding assay
|
[PMID: 26023814]
|
|
CHO
|
EC50 |
|
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1B
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1B
|
[PMID: 12646022]
|
|
A549
|
IC50 |
1.3 2
Compound: Melatonin
|
Growth inhibition of human A549 cells
Growth inhibition of human A549 cells
|
[PMID: 28814374]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human melatonin MT2 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
Intrinsic activity at human melatonin MT2 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
|
[PMID: 24417958]
|
|
CHO
|
IC50 |
1.1 x 10 -10 41
Compound: Melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant MT1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
Displacement of [125I]2-iodomelatonin from human recombinant MT1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
|
[PMID: 27876250]
|
|
AGS
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human AGS cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human melatonin MT2 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
Intrinsic activity at human melatonin MT2 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
|
[PMID: 24417958]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human Melatonin receptor type 1B evaluated on [35S]GTP-gamma-S, binding in Chinese hamster ovarian (CHO) cells
Intrinsic activity at human Melatonin receptor type 1B evaluated on [35S]GTP-gamma-S, binding in Chinese hamster ovarian (CHO) cells
|
[PMID: 12061881]
|
|
CHO
|
EC50 |
1.5 1
Compound: Melatonin
|
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
|
[PMID: 21420861]
|
|
CHO
|
EC50 |
|
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1B
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1B
|
[PMID: 12646022]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human melatonin MT1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
Intrinsic activity at human melatonin MT1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
|
[PMID: 24417958]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human Melatonin receptor type 1B evaluated on [35S]GTP-gamma-S, binding in Chinese hamster ovarian (CHO) cells
Intrinsic activity at human Melatonin receptor type 1B evaluated on [35S]GTP-gamma-S, binding in Chinese hamster ovarian (CHO) cells
|
[PMID: 12061881]
|
|
CHO
|
EC50 |
1.5 1
Compound: Melatonin
|
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
|
[PMID: 21420861]
|
|
CHO
|
EC50 |
|
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
|
[PMID: 20444610]
|
|
CHO
|
EC50 |
|
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1B
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1B
|
[PMID: 12646022]
|
|
CHO
|
EC50 |
|
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1A
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1A
|
[PMID: 12646022]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human melatonin MT1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
Intrinsic activity at human melatonin MT1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
|
[PMID: 24417958]
|
|
HEK293
|
IC50 |
0.53 1
Compound: Melatonin, MLT
|
Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cells
Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cells
|
[PMID: 18372181]
|
|
CHO
|
EC50 |
|
Intrinsic activity evaluated on [35S]GTP -gamma-S binding in hamster ovarian (CHO) cells, stably expressing human Melatonin receptor type 1A
Intrinsic activity evaluated on [35S]GTP -gamma-S binding in hamster ovarian (CHO) cells, stably expressing human Melatonin receptor type 1A
|
[PMID: 12061881]
|
|
CHO-K1
|
IC50 |
0.21 1
Compound: melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant melatonin receptor 1 expressed in CHOK1 cells after 3 hrs
Displacement of [125I]2-iodomelatonin from human recombinant melatonin receptor 1 expressed in CHOK1 cells after 3 hrs
|
[PMID: 23403082]
|
|
BT-549
|
IC50 |
|
Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay
Antiproliferative activity against human BT549 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
C6
|
IC50 |
>40 3
Compound: Melatonin
|
Antiproliferative activity against rat C6 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against rat C6 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
HCT-116
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
EC50 |
|
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
|
[PMID: 20444610]
|
|
CHO
|
EC50 |
|
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1A
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1A
|
[PMID: 12646022]
|
|
HEK293
|
EC50 |
|
Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
|
[PMID: 31204226]
|
|
HEK293
|
EC50 |
|
Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
|
[PMID: 31204226]
|
|
CHO
|
EC50 |
|
Agonist activity at human MT1 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Agonist activity at human MT1 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
|
[PMID: 19329323]
|
|
HEK293
|
EC50 |
|
Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
|
[PMID: 31204226]
|
|
CHO
|
EC50 |
1.5 1
Compound: Melatonin
|
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
|
[PMID: 21420861]
|
|
HepG2
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
EC50 |
|
Intrinsic activity at human melatonin MT1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
Intrinsic activity at human melatonin MT1 receptor expressed in CHO cells assessed as [35S]GTPgammaS binding after 1 hr
|
[PMID: 24417958]
|
|
CHO
|
EC50 |
|
Intrinsic activity evaluated on [35S]GTP -gamma-S binding in hamster ovarian (CHO) cells, stably expressing human Melatonin receptor type 1A
Intrinsic activity evaluated on [35S]GTP -gamma-S binding in hamster ovarian (CHO) cells, stably expressing human Melatonin receptor type 1A
|
[PMID: 12061881]
|
|
HepG2
|
IC50 |
|
Antioxidant activity in human HepG2 cells assessed as reduction in H2O2-induced oxidation by DCFH-DA assay
Antioxidant activity in human HepG2 cells assessed as reduction in H2O2-induced oxidation by DCFH-DA assay
|
[PMID: 23332368]
|
|
HGC-27
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
EC50 |
|
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
Agonist activity at human MT1 receptor expressed in CHO cells by [35S]GTPgamma binding assay
|
[PMID: 20444610]
|
|
MCF7
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
IC50 |
1.1 × 10 -10 41
Compound: Melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant ML1A receptor expressed in CHO cells
Displacement of [125I]2-iodomelatonin from human recombinant ML1A receptor expressed in CHO cells
|
[PMID: 26988801]
|
|
CHO
|
IC50 |
1.1 × 10 -10 41
Compound: Melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant MT1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
Displacement of [125I]2-iodomelatonin from human recombinant MT1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
|
[PMID: 27876250]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
CHO
|
EC50 |
|
Agonist activity at human MT1 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
Agonist activity at human MT1 receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding
|
[PMID: 19329323]
|
|
CHO
|
IC50 |
1.1 x 10 -10 41
Compound: Melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant ML1A receptor expressed in CHO cells
Displacement of [125I]2-iodomelatonin from human recombinant ML1A receptor expressed in CHO cells
|
[PMID: 26988801]
|
|
MDA-MB-231
|
IC50 |
0.9 3
Compound: Melatonin
|
Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
MGC-803
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
CHO
|
IC50 |
1.1 x 10 -10 41
Compound: Melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant MT1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
Displacement of [125I]2-iodomelatonin from human recombinant MT1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method
|
[PMID: 27876250]
|
|
CHO
|
EC50 |
|
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1A
Agonist potency determined by [35S]GTP gamma-S binding assay using CHO cell lines for Melatonin receptor type 1A
|
[PMID: 12646022]
|
|
PC-12
|
IC50 |
|
Neuroprotective activity against amyloid beta (25 to 35 amino acid residues) induced damage in rat PC12 cells assessed as cell viability preincubated for 3 hrs followed by addition of amyloid beta (25 to 35 amino acid residues) for 24 hrs by MTT assay
Neuroprotective activity against amyloid beta (25 to 35 amino acid residues) induced damage in rat PC12 cells assessed as cell viability preincubated for 3 hrs followed by addition of amyloid beta (25 to 35 amino acid residues) for 24 hrs by MTT assay
|
[PMID: 26970662]
|
|
HCT-116
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
HepG2
|
IC50 |
|
Antioxidant activity in human HepG2 cells assessed as reduction in H2O2-induced oxidation by DCFH-DA assay
Antioxidant activity in human HepG2 cells assessed as reduction in H2O2-induced oxidation by DCFH-DA assay
|
[PMID: 23332368]
|
|
SGC-7901
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
HepG2
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
SH-SY5Y
|
EC50 |
> 1 3
Compound: Melatonin
|
Neuroprotective activity against t-BuOOH-induced oxidative stress in human SH-SY5Y cells assessed as inhibition ROS accumulation pre-incubated for 24 hrs before t-BuOOH challnge for 30 mins by DCFH-DA probe based fluorescence assay
Neuroprotective activity against t-BuOOH-induced oxidative stress in human SH-SY5Y cells assessed as inhibition ROS accumulation pre-incubated for 24 hrs before t-BuOOH challnge for 30 mins by DCFH-DA probe based fluorescence assay
|
[PMID: 29420891]
|
|
HGC-27
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
U-251
|
IC50 |
> 40 3
Compound: Melatonin
|
Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
U-87MG ATCC
|
IC50 |
> 40 3
Compound: Melatonin
|
Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
Huh-7
|
CC50 |
|
Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 24 hrs by PrestoBlue assay
Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 24 hrs by PrestoBlue assay
|
[PMID: 36167010]
|
|
HEK293
|
EC50 |
|
Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
|
[PMID: 31204226]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
MCF7
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
MDA-MB-231
|
IC50 |
0.9 3
Compound: Melatonin
|
Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
MGC-803
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
PC-12
|
IC50 |
|
Neuroprotective activity against amyloid beta (25 to 35 amino acid residues) induced damage in rat PC12 cells assessed as cell viability preincubated for 3 hrs followed by addition of amyloid beta (25 to 35 amino acid residues) for 24 hrs by MTT assay
Neuroprotective activity against amyloid beta (25 to 35 amino acid residues) induced damage in rat PC12 cells assessed as cell viability preincubated for 3 hrs followed by addition of amyloid beta (25 to 35 amino acid residues) for 24 hrs by MTT assay
|
[PMID: 26970662]
|
|
SGC-7901
|
IC50 |
>30 3
Compound: Melatonin
|
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
SH-SY5Y
|
EC50 |
|
Neuroprotective activity against t-BuOOH-induced oxidative stress in human SH-SY5Y cells assessed as inhibition ROS accumulation pre-incubated for 24 hrs before t-BuOOH challnge for 30 mins by DCFH-DA probe based fluorescence assay
Neuroprotective activity against t-BuOOH-induced oxidative stress in human SH-SY5Y cells assessed as inhibition ROS accumulation pre-incubated for 24 hrs before t-BuOOH challnge for 30 mins by DCFH-DA probe based fluorescence assay
|
[PMID: 29420891]
|
|
U-251
|
IC50 |
>40 3
Compound: Melatonin
|
Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
U-87MG ATCC
|
IC50 |
>40 3
Compound: Melatonin
|
Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
CHO-K1
|
IC50 |
0.21 1
Compound: melatonin
|
Displacement of [125I]2-iodomelatonin from human recombinant melatonin receptor 1 expressed in CHOK1 cells after 3 hrs
Displacement of [125I]2-iodomelatonin from human recombinant melatonin receptor 1 expressed in CHOK1 cells after 3 hrs
|
[PMID: 23403082]
|
|
HCT-116
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HCT-116 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
HEK293
|
EC50 |
|
Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
Agonist activity at MT1 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
|
[PMID: 31204226]
|
|
HEK293
|
EC50 |
|
Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
Agonist activity at MT2 receptor (unknown origin) expressed in HEK293 cells by Fluo-8 dye-based calcium assay
|
[PMID: 31204226]
|
|
HEK293
|
IC50 |
0.2 1
Compound: Melatonin, MLT
|
Displacement of 2-[125I]iodomelatonin from human MT1 receptor expressed in HEK293 cells
Displacement of 2-[125I]iodomelatonin from human MT1 receptor expressed in HEK293 cells
|
[PMID: 18372181]
|
|
HEK293
|
IC50 |
0.53 1
Compound: Melatonin, MLT
|
Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cells
Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in HEK293 cells
|
[PMID: 18372181]
|
|
HGC-27
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HGC-27 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
HepG2
|
IC50 |
|
Antioxidant activity in human HepG2 cells assessed as reduction in H2O2-induced oxidation by DCFH-DA assay
Antioxidant activity in human HepG2 cells assessed as reduction in H2O2-induced oxidation by DCFH-DA assay
|
[PMID: 23332368]
|
|
HepG2
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
Huh-7
|
CC50 |
|
Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 24 hrs by PrestoBlue assay
Cytotoxicity against human Huh-7 cells assessed as reduction in cell viability incubated for 24 hrs by PrestoBlue assay
|
[PMID: 36167010]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
MCF7
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
MDA-MB-231
|
IC50 |
0.9 3
Compound: Melatonin
|
Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay
Antiproliferative activity against human MDA-MB-231 cells after 24 hrs by MTT assay
|
[PMID: 29144746]
|
|
MGC-803
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human MGC-803 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
Melanophore
|
EC50 |
0.063 1
Compound: melatonin
|
Agonist activity in Xenopus laevis melanophore assessed as potency for pigment aggregation
Agonist activity in Xenopus laevis melanophore assessed as potency for pigment aggregation
|
[PMID: 16759094]
|
|
Melanophore
|
EC50 |
0.23 1
Compound: Melatonin
|
Effective concentration required to produce 50% of the maximal pigment aggregation in Xenopus laevis dermal melanophore cell line
Effective concentration required to produce 50% of the maximal pigment aggregation in Xenopus laevis dermal melanophore cell line
|
[PMID: 9484496]
|
|
PC-12
|
IC50 |
|
Neuroprotective activity against amyloid beta (25 to 35 amino acid residues) induced damage in rat PC12 cells assessed as cell viability preincubated for 3 hrs followed by addition of amyloid beta (25 to 35 amino acid residues) for 24 hrs by MTT assay
Neuroprotective activity against amyloid beta (25 to 35 amino acid residues) induced damage in rat PC12 cells assessed as cell viability preincubated for 3 hrs followed by addition of amyloid beta (25 to 35 amino acid residues) for 24 hrs by MTT assay
|
[PMID: 26970662]
|
|
SGC-7901
|
IC50 |
> 30 3
Compound: Melatonin
|
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
Antiproliferative activity against human SGC-7901 cells assessed as inhibition of cell proliferation measured after 72 hrs by MTT assay
|
[PMID: 33248852]
|
|
SH-SY5Y
|
EC50 |
> 1 3
Compound: Melatonin
|
Neuroprotective activity against t-BuOOH-induced oxidative stress in human SH-SY5Y cells assessed as inhibition ROS accumulation pre-incubated for 24 hrs before t-BuOOH challnge for 30 mins by DCFH-DA probe based fluorescence assay
Neuroprotective activity against t-BuOOH-induced oxidative stress in human SH-SY5Y cells assessed as inhibition ROS accumulation pre-incubated for 24 hrs before t-BuOOH challnge for 30 mins by DCFH-DA probe based fluorescence assay
|
[PMID: 29420891]
|
|
U-251
|
IC50 |
> 40 3
Compound: Melatonin
|
Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human U-251 cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|
|
U-87MG ATCC
|
IC50 |
> 40 3
Compound: Melatonin
|
Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
Antiproliferative activity against human U-87 MG cells assessed as growth inhibition incubated for 72 hrs by CCK-8 assay
|
[PMID: 34091208]
|